Organ Preservation in Rectal Adenocarcinoma: A phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management Academic Article uri icon

Overview

MeSH Major

  • Adenocarcinoma
  • Antineoplastic Combined Chemotherapy Protocols
  • Chemoradiotherapy
  • Consolidation Chemotherapy
  • Induction Chemotherapy
  • Organ Sparing Treatments
  • Rectal Neoplasms

abstract

  • NCT02008656.

publication date

  • October 23, 2015

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4619249

Digital Object Identifier (DOI)

  • 10.1186/s12885-015-1632-z

PubMed ID

  • 26497495

Additional Document Info

start page

  • 767

volume

  • 15

number

  • 1